Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha(1)-Antitrypsin Deficiency.

Perlmutter1

  • 1Department of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, 660 South Euclid Avenue, Box 8208, St. Louis, MO 63110, USA. perlmutter@kids.wustl.edu

Current Treatment Options in Gastroenterology
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lacunarity analysis: A general technique for the analysis of spatial patterns.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·1996
Same author

Experimental limits on the dark matter halo of the galaxy from gravitational microlensing.

Physical review letters·1995
Same author

Polarization properties of quasielastic light scattering in fused-silica optical fiber.

Physical review. B, Condensed matter·1990
Same author

Inverse-power-law light scattering in fused-silica optical fiber.

Physical review letters·1988
Same author

Quantum nondemolition measurements in an optical-fiber ring resonator.

Physical review. A, General physics·1988
Same author

Four-mode squeezing.

Physical review letters·1987

Caring for alpha-1 antitrypsin (alpha(1)-AT) deficiency liver disease involves managing complications and cholestatic injury. Transplant referral timing depends on life functioning interference, not just cirrhosis presence.

Area of Science:

  • Hepatology
  • Genetic Liver Diseases
  • Transplantation Medicine

Background:

  • Alpha-1 antitrypsin (alpha(1)-AT) deficiency is a genetic disorder that can lead to chronic liver disease.
  • Management primarily focuses on supportive care for complications like gastrointestinal bleeding, ascites, and hepatic encephalopathy.
  • Patients may also exhibit cholestatic injury, including pruritus, hypercholesterolemia, and fat-soluble vitamin deficiencies.

Purpose of the Study:

  • To outline the clinical management of liver disease in alpha(1)-antitrypsin (alpha(1)-AT) deficiency.
  • To address the critical challenge of determining the optimal timing for liver transplantation referral in these patients.

Main Methods:

  • This review synthesizes current clinical practices and expert recommendations for managing alpha(1)-AT deficiency-related liver disease.

Related Experiment Videos

  • It emphasizes a multidisciplinary approach involving hepatologists, transplant specialists, and patient-family input.

    • Main Results:

    • Supportive care addresses complications of chronic liver disease and cholestatic manifestations.
    • Liver transplantation referral timing is complex, especially in patients with nonprogressive disease or mild dysfunction.
    • Referral decisions should integrate objective disease markers with subjective assessments of life functioning impact.

    Conclusions:

    • Effective management of alpha(1)-AT deficiency liver disease requires comprehensive supportive care.
    • The decision for liver transplantation should be individualized, considering the patient's overall quality of life and functional status, not solely based on established cirrhosis or synthetic dysfunction.